COVERAGE ENGINE · PRODUCT + DIAGNOSIS + INSURANCE

How do I get Kimmtrak
through my insurance?

Kimmtrak · tebentafusp-tebn · gp100 peptide-HLA T-cell engager · IV infusion

Coverage first → benefit/formulation → assistance
Kimmtrak / tebentafusp-tebn coverage engine.

Rare oncology infusion for HLA-A*02:01-positive unresectable or metastatic uveal melanoma. HLA typing, disease site, weekly administration, cytokine-release monitoring and early prolonged observation make the benefit pathway distinctive.

No account, member ID, name, date of birth or email is needed. Your selections stay in this page session.

1
WHY IS THIS MEDICINE BEING GIVEN?

Choose the diagnosis / reason.

Coverage rules can change by diagnosis and sometimes by formulation.

AFTER COVERAGE

Then solve the patient’s out-of-pocket cost.

Financial assistance only helps after the correct product/formulation and benefit path are known.

KIMMTRAK CONNECT patient support →

Important

MedicineCostHelp is an educational navigation tool, not an insurer and not a coverage determination. Medical policies, billing codes, product preferences and benefit placement can change. Sources in this batch were checked 2026-08-20.

Search another expensive medicine →